A novel chitosan-based doxepin nano-formulation for chemotherapy-induced oral mucositis: a randomized, double-blinded, placebo-controlled clinical trial
CONCLUSION: Chitosan-based doxepin nano-formulation might be a promising alternative for routine treatments of oral mucositis.PMID:37668810 | DOI:10.1007/s10787-023-01325-7
Source: Cancer Control - Category: Cancer & Oncology Authors: Nazafarin Samiraninezhad Mostafa Rezaee Ahmad Gholami Ali Amanati Maryam Mardani Source Type: research
More News: Benadryl | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Conferences | Doxepin | International Medicine & Public Health | Magnesium | Nanotechnology | Nurses | Nursing | Oral Cancer | WHO